id | C00003468 |
---|---|
Name | (+)-Pimaric acid |
CAS RN | 127-27-5 |
Standard InChI | InChI=1S/C20H30O2/c1-5-18(2)12-9-15-14(13-18)7-8-16-19(15,3)10-6-11-20(16,4)17(21)22/h5,13,15-16H,1,6-12H2,2-4H3,(H,21,22)/t15-,16+,18+,19+,20+/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C20H30O2/c1-5-18(2)12-9-15-14(13-18)7-8-16-19(15,3)10-6-11-20(16,4)17(21)22/h5,13,15-16H,1,6-12H2,2-4H3,(H,21,22) |
Phytochemical cluster | No. 48 |
---|---|
KCF-S cluster | No. 208 |
By standard InChI | CHEMBL1410398 |
---|---|
By standard InChI Main Layer | CHEMBL513197 CHEMBL1397211 CHEMBL1410398 CHEMBL1735595 |
By LinkDB | C09159 |
---|
By CAS RN | C008911 |
---|
class name | count |
---|---|
Spermatophyta | 1 |
family name | count |
---|---|
Pinaceae | 1 |
KNApSAcK organism | *ID | *family | *plant class | *kingdom |
---|---|---|---|---|
Pinus spp. | 3318 | Pinaceae | Spermatophyta | Viridiplantae |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL1735595 |
CHEMBL1794585
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL1410398 |
CHEMBL1614027
(1)
|
0 / 1 |
P47870 | Gamma-aminobutyric acid receptor subunit beta-2 | GABA-A beta | CHEMBL513197 |
CHEMBL2148420
(1)
CHEMBL2148421
(1)
|
0 / 0 |
P14867 | Gamma-aminobutyric acid receptor subunit alpha-1 | GABA-A alpha | CHEMBL513197 |
CHEMBL2148420
(1)
CHEMBL2148421
(1)
|
1 / 1 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | CHEMBL1735595 |
CHEMBL1794584
(1)
|
2 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL1397211 |
CHEMBL2114843
(1)
|
0 / 0 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | CHEMBL1397211 |
CHEMBL2114788
(1)
|
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL1735595 |
CHEMBL2114810
(1)
|
7 / 3 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL1397211 |
CHEMBL1794569
(1)
|
1 / 1 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | CHEMBL1735595 |
CHEMBL1738588
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL1410398 |
CHEMBL1613777
(1)
|
1 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL1397211 |
CHEMBL1737991
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL1397211 |
CHEMBL1738184
(1)
|
0 / 0 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | CHEMBL1735595 |
CHEMBL1964002
(1)
|
1 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
C008911 | 1386 |
ATF2
CRE-BP1 CREB2 HB16 TREB7 |
activating transcription factor 2 (EC:2.3.1.48) | [pimaric acid co-treated with TNF protein] results in decreased expression of ATF2 protein modified form |
affects cotreatment
/ decreases expression |
protein |
22705379
|
C008911 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | pimaric acid inhibits the reaction [JUN protein results in increased expression of FOS protein modified form] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 2353 |
FOS
AP-1 C-FOS p55 |
FBJ murine osteosarcoma viral oncogene homolog | pimaric acid inhibits the reaction [TNF protein results in increased expression of FOS protein] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 3725 |
JUN
AP-1 AP1 c-Jun |
jun proto-oncogene | pimaric acid inhibits the reaction [JUN protein results in increased expression of FOS protein modified form] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 3727 |
JUND
AP-1 |
jun D proto-oncogene | [pimaric acid co-treated with TNF protein] results in decreased expression of JUND protein |
affects cotreatment
/ decreases expression |
protein |
22705379
|
C008911 | 5594 |
MAPK1
ERK ERK2 ERT1 MAPK2 P42MAPK PRKM1 PRKM2 p38 p40 p41 p41mapk |
mitogen-activated protein kinase 1 (EC:2.7.11.24) | pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22705379
|
C008911 | 5595 |
MAPK3
ERK-1 ERK1 ERT2 HS44KDAP HUMKER1A P44ERK1 P44MAPK PRKM3 p44-ERK1 p44-MAPK |
mitogen-activated protein kinase 3 (EC:2.7.11.24) | pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22705379
|
C008911 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | pimaric acid inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein] |
decreases reaction
/ increases activity / increases expression |
protein |
22705379
|
C008911 | 4318 |
MMP9
CLG4B GELB MANDP2 MMP-9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) | pimaric acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] |
decreases reaction
/ increases expression |
mRNA |
22705379
|
C008911 | 5970 |
RELA
NFKB3 p65 |
v-rel avian reticuloendotheliosis viral oncogene homolog A | pimaric acid inhibits the reaction [TNF protein results in increased expression of RELA protein] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | [pimaric acid co-treated with TNF protein] results in decreased expression of ATF2 protein modified form |
affects cotreatment
/ decreases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | [pimaric acid co-treated with TNF protein] results in decreased expression of JUND protein |
affects cotreatment
/ decreases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | pimaric acid inhibits the reaction [TNF protein results in increased expression of and results in increased activity of MMP9 protein] |
decreases reaction
/ increases activity / increases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | pimaric acid inhibits the reaction [TNF protein results in increased expression of FOS protein] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | pimaric acid inhibits the reaction [TNF protein results in increased expression of MMP9 mRNA] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | pimaric acid inhibits the reaction [TNF protein results in increased expression of RELA protein] |
decreases reaction
/ increases expression |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK1 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22705379
|
C008911 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | pimaric acid inhibits the reaction [TNF protein results in increased phosphorylation of MAPK3 protein] |
decreases reaction
/ increases phosphorylation |
protein |
22705379
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#114500 | Colorectal cancer; crc |
P84022
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#611136 | Epilepsy, juvenile myoclonic, susceptibility to, 5; ejm5 |
P14867
|
#137800 | Glioma susceptibility 1; glm1 |
O75874
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H01205 | Coumarin resistance |
P11712
(related)
|
H00808 | Idiopathic generalized epilepsies (IGEs) |
P14867
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|